Jump to content

Extracorporeal shockwave therapy

From Wikipedia, the free encyclopedia
(Redirected from ESWL)
"shock wave therapy" redirects here. For the use of electrical shocks in therapy, see Electroconvulsive therapy.
Extracorporeal shockwave therapy
ESWT device (EMS Swiss DolorClast)
ICD-10-PCS6A93
ICD-9-CM98.5
ESWT device

Extracorporeal shockwave therapy (ESWT) is a treatment using powerful acoustic pulses which is mostly used to treat kidney stones and in physical therapy and orthopedics.[1][2]

Medical uses

[edit]
Some of the passed fragments of a 1-cm calcium oxalate stone that was smashed using lithotripsy

The most common use of extracorporeal shockwave therapy (ESWT) is for lithotripsy to treat kidney stones[3] (urinary calculosis) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones[4] and pancreatic stones.[5]

In the UK, the National Institute for Health and Care Excellence (NICE) found that the evidence for ESWT in the majority of indications is conflicting, and therefore ESWT should only be used where there are special arrangements for clinical governance and audit.[6] Two 2017 reviews had similar findings, with moderate level evidence at best.[7][8]

Extracorporeal shockwave therapy is used as a second line measure to treat tennis elbow,[9][10] shoulder rotator cuff pain,[11][12] Achilles tendinitis,[13][14] plantar fasciitis,[15][16] and greater trochanteric pain syndrome.[17]

ESWT is also used to promote bone healing and treat bone necrosis.[18] It is an effective alternative to surgical treatment of non-healing fractures.[19]

ESWT is used for wound healing and has shown positive results in short-term and long-term outcomes in diabetic patients with foot ulcers.[20] Randomised controlled trials into the use of ESWT for healing venous leg ulcers are needed as there is a lack of evidence in this area.[21]

Low-intensity extracorporeal shock wave therapy has been used as a treatment for erectile dysfunction. It differs from palliative options by aiming to restore natural erectile function by inducing cellular microtrauma, triggering the release of angiogenic factors and promoting neovascularization in treated tissue. This mechanism is distinct from the high-intensity shock waves used in lithotripsy and medium-intensity shock waves used for anti-inflammatory purposes in orthopedics. Clinical studies, including double-blind randomized trials, have demonstrated LI-ESWT's ability to significantly improve erectile function and penile hemodynamics in men with vasculogenic ED.[22][23]

Procedure

[edit]

The lithotripter attempts to break up the stone with minimal collateral damage by using an externally applied, focused, high-intensity acoustic pulse. The patient is usually sedated or anesthetized for the procedure in order to help them remain still and reduce possible discomfort.[24] Sedation is not required in its application for soft tissue injuries.

History

[edit]

Beginning in 1969 and funded by the German Ministry of Defense, Dornier began a study of the effects of shock waves on tissue. In 1972, on the basis of preliminary studies performed by Dornier Medical Systems, an agreement was reached with Egbert Schmiedt, director of the urologic clinic at the University of Munich. The development of the Dornier lithotripter progressed through several prototypes, ultimately culminating in February 1980 with the first treatment of a human by shockwave lithotripsy (SWL). The production and distribution of the Dornier HM3 lithotripter began in late 1983, and SWL was approved by the U.S. Food and Drug Administration in 1984.[25]

In the 1980s people using ESWT for kidney stones noticed that it appeared to increase bone density in nearby bones, leading them to explore it for orthopedic purposes.[26]

Research

[edit]

In response to concerns raised by NICE, in 2012 a study called the Assessment of the Effectiveness of ESWT for Soft Tissue Injuries was launched (ASSERT).[6]

As of 2018 use of ESWT had been studied as a potential treatment for chronic prostatitis/chronic pelvic pain syndrome in three small studies; there were short-term improvements in symptoms and few adverse effects, but the medium-term results are unknown, and the results are difficult to generalize due to the low quality of the studies.[27]

Veterinary use

[edit]

ESWT is commonly used for treating orthopedic problems in horses, including tendon and ligament injuries, kissing spine, navicular syndrome, and arthritis. The evidence for these uses is weak.[26]

Physiotherapy use

[edit]

ESWT is used in physical therapy for pain reduction, increase in metabolism at the cellular level, revascularisation, and recovering normal muscle tone following various disorders.[28] The use of ESWT was demonstrated in patients with frozen shoulders compared to therapeutic ultrasound with exercises.[29]

Research suggests that ESWT can accelerate the blood flow, facilitating the healing of the inflamed Achilles tendon.[citation needed] In one study involving 23 patients with chronic Achilles tendinopathy, 20 reported improvement in their condition and pain scores after ESWT; three saw no change, and none reported any worsening.[30]

See also

[edit]

References

[edit]
  1. ^ Wang, Ching-Jen (2012). "Extracorporeal shockwave therapy in musculoskeletal disorders". Journal of Orthopaedic Surgery and Research. 7 (1): 11. doi:10.1186/1749-799X-7-11. PMC 3342893. PMID 22433113.
  2. ^ Chung, Bryan; Wiley, J. Preston (2002). "Extracorporeal Shockwave Therapy". Sports Medicine. 32 (13): 851–865. doi:10.2165/00007256-200232130-00004. PMID 12392445. S2CID 30387795.
  3. ^ Setthawong V, Srisubat A, Potisat S, Lojanapiwat B, Pattanittum P (August 2023). "Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones". The Cochrane Database of Systematic Reviews. 2023 (8): CD007044. doi:10.1002/14651858.CD007044.pub4. PMC 10392035. PMID 37526261.
  4. ^ "Salivary duct stones". MedlinePlus Medical Encyclopedia. U.S. National Library of Medicine.
  5. ^ Hayes JM, Ding SL (September 2012). "Pancreatic stone and treatment using ERCP and ESWL procedures: a case study and review". The New Zealand Medical Journal. 125 (1361): 89–97. PMID 22960720.
  6. ^ a b Maffulli G, Hemmings S, Maffulli N (September 2014). "Assessment of the Effectiveness of Extracorporeal Shock Wave Therapy (ESWT) For Soft Tissue Injuries (ASSERT): An Online Database Protocol". Translational Medicine @ UniSa. 10: 46–51. PMC 4140430. PMID 25147767.
  7. ^ Korakakis V, Whiteley R, Tzavara A, Malliaropoulos N (March 2018). "The effectiveness of extracorporeal shockwave therapy in common lower limb conditions: a systematic review including quantification of patient-rated pain reduction". British Journal of Sports Medicine. 52 (6): 387–407. doi:10.1136/bjsports-2016-097347. PMID 28954794.
  8. ^ Steuri R, Sattelmayer M, Elsig S, Kolly C, Tal A, Taeymans J, Hilfiker R (September 2017). "Effectiveness of conservative interventions including exercise, manual therapy and medical management in adults with shoulder impingement: a systematic review and meta-analysis of RCTs". British Journal of Sports Medicine. 51 (18): 1340–1347. doi:10.1136/bjsports-2016-096515. PMC 5574390. PMID 28630217.
  9. ^ "Extracorporeal shockwave therapy for refractory tennis elbow". Interventional procedures guidance. National Institute for Health and Clinical Excellence. August 2009. IPG313.
  10. ^ Thiele S, Thiele R, Gerdesmeyer L (December 2015). "Lateral epicondylitis: This is still a main indication for extracorporeal shockwave therapy". International Journal of Surgery. 24 (Pt B): 165–170. doi:10.1016/j.ijsu.2015.09.034. PMID 26455532.
  11. ^ "Extracorporeal shockwave lithotripsy for calcific tendonitis (tendinopathy) of the shoulder". Interventional procedures guidance. National Institute for Health and Clinical Excellence. November 2003. IPG21.
  12. ^ Louwerens JK, Sierevelt IN, van Noort A, van den Bekerom MP (August 2014). "Evidence for minimally invasive therapies in the management of chronic calcific tendinopathy of the rotator cuff: a systematic review and meta-analysis". Journal of Shoulder and Elbow Surgery. 23 (8): 1240–1249. doi:10.1016/j.jse.2014.02.002. PMID 24774621.
  13. ^ "Extracorporeal shockwave therapy for refractory Achilles tendinopathy". Interventional procedures guidance. National Institute for Health and Clinical Excellence. August 2009. IPG312.[needs update]
  14. ^ Wiegerinck JI, Kerkhoffs GM, van Sterkenburg MN, Sierevelt IN, van Dijk CN (June 2013). "Treatment for insertional Achilles tendinopathy: a systematic review". Knee Surgery, Sports Traumatology, Arthroscopy. 21 (6): 1345–1355. doi:10.1007/s00167-012-2219-8. PMID 23052113. S2CID 2214735.
  15. ^ "Extracorporeal shockwave therapy for refractory plantar fasciitis". Interventional procedures guidance. National Institute for Health and Clinical Excellence. August 2009. IPG311.
  16. ^ Yin MC, Ye J, Yao M, Cui XJ, Xia Y, Shen QX, et al. (August 2014). "Is extracorporeal shock wave therapy clinical efficacy for relief of chronic, recalcitrant plantar fasciitis? A systematic review and meta-analysis of randomized placebo or active-treatment controlled trials". Archives of Physical Medicine and Rehabilitation. 95 (8): 1585–1593. doi:10.1016/j.apmr.2014.01.033. PMID 24662810.
  17. ^ "Extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome". Interventional procedures guidance. National Institute for Health and Clinical Excellence. January 2011. IPG376.
  18. ^ Cheng JH, Wang CJ (December 2015). "Biological mechanism of shockwave in bone". International Journal of Surgery. 24 (Pt B): 143–146. doi:10.1016/j.ijsu.2015.06.059. PMID 26118613.
  19. ^ Kong FR, Liang YJ, Qin SG, Li JJ, Li XL (January 2010). "[Clinical application of extracorporeal shock wave to repair and reconstruct osseous tissue framework in the treatment of avascular necrosis of the femoral head (ANFH)]". Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology (in Chinese). 23 (1): 12–15. PMID 20191955.
  20. ^ Wang CJ, Cheng JH, Kuo YR, Schaden W, Mittermayr R (December 2015). "Extracorporeal shockwave therapy in diabetic foot ulcers". International Journal of Surgery. 24 (Pt B): 207–209. doi:10.1016/j.ijsu.2015.06.024. PMID 26079500.
  21. ^ Cooper B, Bachoo P (June 2018). "Extracorporeal shock wave therapy for the healing and management of venous leg ulcers". The Cochrane Database of Systematic Reviews. 2018 (6): CD011842. doi:10.1002/14651858.CD011842.pub2. PMC 6513251. PMID 29889978.
  22. ^ Bocchino, Alessia Celeste; Pezzoli, Marta; Martínez-Salamanca, Juan Ignacio; Russo, Giorgio Ivan; Lo Giudice, Arturo; Cocci, Andrea (March 2023). "Low-intensity extracorporeal shock wave therapy for erectile dysfunction: Myths and realities". Investigative and Clinical Urology. 64 (2): 118–125. doi:10.4111/icu.20220327. ISSN 2466-0493. PMC 9995960. PMID 36882170.
  23. ^ Gruenwald, Ilan; Appel, Boaz; Kitrey, Noam D.; Vardi, Yoram (April 2013). "Shockwave treatment of erectile dysfunction". Therapeutic Advances in Urology. 5 (2): 95–99. doi:10.1177/1756287212470696. ISSN 1756-2872. PMC 3607492. PMID 23554844.
  24. ^ "Lithotrypsy" National Kidney Foundation, Accessed February 6, 2017
  25. ^ "Gastroenterology and Urology Devices; Reclassification of the Extracorporeal Shock Wave Lithotripter AGENCY: Food and Drug Administration, HHS ACTION: Proposed rule". Federal Register (US Government). February 8, 1999. Retrieved February 6, 2017.
  26. ^ a b Chamberlain GA, Colborne GR (2016). "A review of the cellular and molecular effects of extracorporeal shockwave therapy". Veterinary and Comparative Orthopaedics and Traumatology. 29 (2): 99–107. doi:10.3415/VCOT-15-04-0057. PMID 26846274. S2CID 19280257. Open access icon
  27. ^ Franco JV, Turk T, Jung JH, Xiao YT, Iakhno S, Garrote V, Vietto V (May 2018). "Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome". The Cochrane Database of Systematic Reviews. 2018 (5): CD012551. doi:10.1002/14651858.CD012551.pub3. PMC 6494451. PMID 29757454.
  28. ^ Gündüz R, Malas FÜ, Borman P, Kocaoğlu S, Özçakar L (May 2012). "Physical therapy, corticosteroid injection, and extracorporeal shock wave treatment in lateral epicondylitis. Clinical and ultrasonographical comparison". Clinical Rheumatology. 31 (5): 807–812. doi:10.1007/s10067-012-1939-y. PMID 22278162. S2CID 13109216.
  29. ^ Muthukrishnan R, Rashid AA, Al-Alkharji F (July 2019). "The effectiveness of extracorporeal shockwave therapy for frozen shoulder in patients with diabetes: randomized control trial". Journal of Physical Therapy Science. 31 (7): 493–497. doi:10.1589/jpts.31.493. PMC 6642889. PMID 31417208.
  30. ^ Fridman R, Cain JD, Weil L, Weil L (November–December 2008). "Extracorporeal shockwave therapy for the treatment of Achilles tendinopathies: a prospective study". Journal of the American Podiatric Medical Association. 98 (6): 466–468. doi:10.7547/0980466. PMID 19017855.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Extracorporeal_shockwave_therapy&oldid=1250721908"